Results 41 to 50 of about 6,319 (215)
Is lysate-based human leukocyte antigen crossmatch a reliable method to contraindicate a transplant?
The presence of preformed cytotoxic donor-specific antibodies (DSAs) has been associated with inferior allograft outcomes in the immediate posttransplant period.
Shruti Tapiawala +3 more
doaj +1 more source
Abstract Background Human monoclonal (MoAb) anti‐CD38 antibodies, such as daratumumab, are used to treat diseases such as multiple myeloma. Because red blood cells (RBCs) express CD38, these MoAbs interfere with antibody screening and crossmatching in blood banks.
Ayda Javanbakht +3 more
wiley +1 more source
The present and future crossmatch [PDF]
Peer Reviewed ; http://deepblue.lib.umich.edu/bitstream/2027.42/72806/1/j.1537-2995.1992.32993110747.x ...
openaire +3 more sources
Abstract Background Perioperative autologous transfusion, encompassing intraoperative cell salvage (ICS), acute normovolemic hemodilution (ANH), and autologous component production, is integral to patient blood management. Association for the Advancement of Blood and Biotherapies (AABB) has published comprehensive quality standards, yet perioperative ...
Gagan Mathur +7 more
wiley +1 more source
Allografting patients with human leukocyte antigens (HLA) which are recognized by preformed antibodies constitutes the main cause for hyper-acute or acute rejections.
G. Schlaf +3 more
doaj +1 more source
Abstract Background In patients with variant RhD phenotypes, serologic reactions for partial RHD genotypes are indistinguishable from other variants. Study Design and Methods In two US transfusion services, patients were typed for RhD by automated microplate RhD typing (Werfen, Norcross, GA) using two directly agglutinating IgM anti‐D reagents, MS201 ...
Vidyadhari Karne +4 more
wiley +1 more source
Background. HLA incompatible renal transplantation still remains one of best therapeutic options for a subgroup of patients who are highly sensitized and difficult to match but not much is known about its long-term graft and patient survival.
Nithya Krishnan, MD, FRCP +14 more
doaj +1 more source
HUBUNGAN FAKTOR RISIKO ALOIMUNISASI DENGAN KEJADIAN INKOMPATIBILITAS CROSSMATCH PADA PASIEN KEGANASAN DARAH DEWASA YANG DITRANSFUSI PACKED RED CELL BERULANG DI RSUP DR M DJAMIL PADANG [PDF]
Pasien keganasan darah cenderung mendapatkan transfusi packed red cell (PRC) berulang yang berakibat pembentukan aloantibodi yang dapat dideteksi pada pemeriksaan crossmatch.
Dwi, Putri Herinda
core +1 more source
Abstract Background Studies suggest that recipients of pathogen reduced (PR) platelets in platelet additive solution (PAS) experience inferior increments when compared to platelets in plasma (PS); however, few real‐world studies have confirmed these observations. In this single‐center study, we evaluated responses to PS and PAS/PR platelets in platelet‐
Olivia McClellan +6 more
wiley +1 more source
Methods of crossmatch testing prior to kidney transplantation are not standardized and there are limited large-scale data on the use and outcomes implications of crossmatch modality.
Salvalaggio Paolo +7 more
doaj

